Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 41 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Kalogeras, Konstantine T [Clear All Filters]
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients..
Cancer Chemother Pharmacol. 75(6), 1289-301.
(2015). Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab..
Transl Oncol. 12(5), 739-748.
(2019). Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?.
Cancer Immunol Immunother.
(2020). Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression..
Anticancer Res. 34(9), 4949-62.
(2014). Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)..
PLoS One. 8(7), e70634.
(2013). Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer..
Oral Oncol. 50(4), 298-305.
(2014). Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer..
Anticancer Res. 37(5), 2323-2334.
(2017). Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study..
Breast Cancer Res Treat. 127(1), 179-93.
(2011). Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer..
Anticancer Res. 34(11), 6495-503.
(2014). The Role of CXCL13 and CXCL9 in Early Breast Cancer..
Clin Breast Cancer. 20(1), e36-e53.
(2020). Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research..
Virchows Arch. 462(2), 141-54.
(2013).
(2015).
(2012).
(2009).
The upgraded role of HER3 and HER4 receptors in breast cancer..
Crit Rev Oncol Hematol. 74(2), 73-8.
(2010).
(2012).